BioSpace News Archive

Policy

Bristol-Myers Squibb Company and AstraZeneca PLC Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) for the Treatment of Type 2 Diabetes

July 23, 2008
·
3 min read
Drug Development

Introgen Therapeutics, Inc. Release: ADVEXIN(R) Shows Statistically Significant Six-Month and Overall Survival Benefit as Compared to Methotrexate in Prospectively Defined Biomarker Patient Population

July 23, 2008
·
7 min read
Deals

RadNet Acquires Leading Neuroradiology Imaging Center in Delaware

July 23, 2008
·
4 min read
Mpathy Medical Secures Additional Funding

July 23, 2008
·
2 min read
Business

Tomas Leanderson Appointed New President & CEO for Active Biotech AB

July 23, 2008
·
1 min read
Policy

NexMed Receives FDA Non Approvable Letter for ED Product

July 23, 2008
·
3 min read
IBM Corporation First-of-a-Kind Technology to Help Doctors Care for Premature Babies

July 23, 2008
·
3 min read
Leading Bioscience Fund GBS Invests $6 Million in Xenome Ltd

July 23, 2008
·
3 min read
Drug Development

Duska Therapeutics, Inc. Submits Phase 3 ATPace(TM) Protocol to FDA for Comment

July 23, 2008
·
6 min read
Drug Development

Helicon Therapeutics Study of HT-0712 on Primate Memory Formation Reveals Significant Enhancement

July 23, 2008
·
2 min read